Emcure Pharmaceuticals Limited — Updates, 22-12-2025: Press Release
22-12-2025 | 11:41 am
22-12-2025 | 11:41 am
Emcure launched Poviztra® (semaglutide injection) for weight management in India, becoming the first Indian distributor. Priced from ₹8790/month, this aims to address India's obesity crisis and leverage Emcure's broad distribution network for advanced therapy access.
No comments yet. Be the first to comment!
